Gel formulations for guiding radiotherapy

Thomas Lars Andresen (Inventor), Rasmus Irming Jølck (Inventor), Morten Albrechtsen (Inventor)

Research output: Patent

26 Downloads (Pure)


The present invention describes an X-ray contrast composition for local administration, wherein the X-ray contrast composition exhibits contrast properties and wherein at least 60% of an administrated amount of said X-ray contrast composition remains more than 24 hours within 10 cm from an injection point when the X-ray contrast composition is administrated to a human or animal body.
Original languageEnglish
IPCA61K 49/ 04 A I
Patent numberEP3003397
Filing date24/05/2013
Priority date23/05/2014
Priority numberWO2014EP60673
Publication statusPublished - 13 Apr 2016

Bibliographical note

Also published as: AU2014270358A1; AU2014270358B2; BR112015029144A2; CA2913100A1; CN105407927A; CN105407927B; EP3003397A1; WO2014187962A1; HK1223545A1; IL242676A; JP2016519154A; JP6537498B2; KR20160032008A; MX2015016155A; RU2015154681A; RU2703303C2; US2016089454A1; US10561746B2


Dive into the research topics of 'Gel formulations for guiding radiotherapy'. Together they form a unique fingerprint.

Cite this